U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

EMD Group Holding Inc. has received a federal tax lien notice from the Internal Revenue Service indicating it owes over $33.2 ...

The BRITE program and its partnerships with local universities provided Udemadu with critical hands-on training in cell culture and lab techniques. This provided a strong foundation that made his ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for $600 million, it said ahead of its Capital ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...

The transaction, expected to close in the first half of this year, will cost Novartis $925 million upfront with potential ...

VMX 2025, the world’s largest veterinary conference, drew about 30,000 attendees from 86 countries to see the latest ...

The rise of misinformation online has helped fringe health ideas go mainstream and eased RFK Jr.'s path to confirmation as ...

with trillions spent on life sciences R&D every year to advance new drug discoveries. That R&D takes place not only at big pharma companies—household names such as Pfizer and Merck—but also at smaller ...

NAYA Biosciences (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women’s health, today ...